Abstract
Conclusion
Therapeutic doses of sulfanilamide commonly produce macrocytic anemia and a normoblastic bone-marrow reaction. In the acute hemolytic anemia the bone marrow shows a more marked normoblastic reaction with predominance of young forms.
Get full access to this article
View all access options for this article.